By switaschek, 15 October, 2020 Lung Cancer Screening in Asymptomatic Pts | USPSTF, ACCP, ACS, AATS, etc. Guideline Synthesis
By rray, 15 October, 2024 If using flecainide or propafenone consider combo w BB non DHP CCB to prevent 1 1 conduction if rhythm transforms to AFL IIa C
By rray, 15 October, 2024 If no impaired LV systolic function severe LV hypertrophy CAD flecainide or propafenone recommended I A
By rray, 15 October, 2024 Amiodarone if HFrEF w careful consideration and monitoring for extracardiac toxicity I A
By rray, 15 October, 2024 If recent onset AF w o severe LV hypertrophy HFrEF CAD IV flecainide or propafenone recommended I A
By rray, 15 October, 2024 Consider a wait and see approach for spontaneous conversion to SR w in 48h of AF onset in pts w o hemodynamic compromise vs immediate cardioversion IIa B
By rray, 15 October, 2024 Percutaneous LAAO requires postprocedure anticoagulation but surgical LAAO does not
By rray, 15 October, 2024 Risks stroke major bleeding device related thrombus pericardial effusion vascular complications and death